Published in Transplantation on January 01, 1976
Mechanism of cellular suppression induced by oral tilorone treatment of mice. Infect Immun (1980) 0.81
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Simultaneous activation of NADPH oxidase-related proton and electron currents in human neutrophils. Proc Natl Acad Sci U S A (2000) 1.58
Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. J Leukoc Biol (1999) 1.49
Interactions between NADPH oxidase-related proton and electron currents in human eosinophils. J Physiol (2001) 1.46
Purification of cardiac myosin. Application to hypertrophied myocardium. Biochim Biophys Acta (1975) 1.37
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol (1984) 1.35
Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol (1992) 1.24
Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid. J Physiol (2001) 1.24
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J Immunol (1980) 1.19
Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood (1997) 1.05
Noncytotoxic activation of neutrophils by eosinophil granule major basic protein. Effect on superoxide anion generation and lysosomal enzyme release. J Immunol (1990) 1.02
Quantitative endotoxin determination in blood with a chromogenic substrate. Clin Chim Acta (1981) 1.01
Tilorone: its selective effects on humoral and cell-mediated immunity. Proc Soc Exp Biol Med (1974) 0.99
Selective depletion of thymus dependent areas in lymphoid tissue by tilorone. Proc Soc Exp Biol Med (1974) 0.97
A novel and highly divergent homolog of human eosinophil granule major basic protein. J Biol Chem (1999) 0.96
High school students' long-term retention of sex education information. J Sch Health (1985) 0.94
Methylxanthine bronchodilators potentiate multiple human neutrophil functions. J Immunol (1987) 0.94
Sarcoidosis associated with autoimmune thrombocytopenia and selective IgA deficiency. Scand J Haematol (1982) 0.93
A loglogistic model for altitude decompression sickness. Aviat Space Environ Med (1998) 0.93
Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis. Inflamm Res (2004) 0.92
Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Biochim Biophys Acta (1988) 0.92
Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment? Br J Haematol (1995) 0.92
New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation. J Med Chem (1993) 0.91
Analysis of signaling events associated with activation of neutrophil superoxide anion production by eosinophil granule major basic protein. Blood (1995) 0.88
Endotoxin testing in blood. Prog Clin Biol Res (1987) 0.88
The anti-inflammatory actions of tilorone hydrochloride. Proc Soc Exp Biol Med (1975) 0.87
The role of basophils in inflammatory reactions. J Invest Dermatol (1978) 0.87
Surface expression of lactoferrin by resting neutrophils. Biochem Biophys Res Commun (2000) 0.86
Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures. Am J Clin Pathol (1984) 0.84
Functional integrity of the SH1 site in myosin from hypertrophied myocardium. Biochim Biophys Acta (1977) 0.84
Cyclic nucleotides in immune responses and allergy. Adv Cyclic Nucleotide Res (1980) 0.84
Molecular cloning and expression of an inwardly rectifying K(+) channel from bovine corneal endothelial cells. Invest Ophthalmol Vis Sci (2000) 0.82
Separation and isolation of mycobacterial antigens by continuous-flow electrophoresis. Am Rev Respir Dis (1972) 0.82
Optimalization of a chromogenic assay for endotoxin in blood. Prog Clin Biol Res (1985) 0.82
Massive vincristine overdose: failure of leucovorin to reduce toxicity. Cancer Treat Rep (1982) 0.81
Stimulation of neutrophil interleukin-8 production by eosinophil granule major basic protein. Am J Respir Cell Mol Biol (1999) 0.81
The effect of tilorone on immunoglobulin-bearing lymphocytes (B cells) in peripheral blood and spleens of mice. J Reticuloendothel Soc (1976) 0.81
IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. J Immunol (1995) 0.80
IgE-mediated basophil phenomena: quantitation, control, inflammatory interactions. Immunol Rev (1978) 0.80
Effect of tilorone hydrochloride on the lymphoid and interferon responses of athymic mice. Proc Soc Exp Biol Med (1976) 0.79
Increases in cytosolic Ca2+ accompany basophil activation by eosinophil granule major basic protein. Immunol Lett (1997) 0.79
A flow cytometric procedure for the isolation of antigenically responsive human basophils. J Immunol Methods (1986) 0.79
IMVP-16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma. Hematol Oncol (1992) 0.79
Human basophils selectively express the Fc gamma RII (CDw32) subtype of IgG receptor. J Allergy Clin Immunol (1989) 0.79
Eosinophil major basic protein enhances the expression of neutrophil CR3 and p150,95. J Allergy Clin Immunol (1993) 0.78
Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils. Biochim Biophys Acta (1986) 0.78
Potentiation of human basophil histamine release by protamine: a new role for a polycation recognition site. Mol Immunol (1986) 0.78
Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse. Agents Actions (1993) 0.78
Galactosamine hepatitis, endotoxemia, and lactulose. Hepatology (1983) 0.78
Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils. J Leukoc Biol (1992) 0.78
Growth of aortic explants and arteriosclerosis. Nature (1967) 0.78
Validity of the endotoxin assay in post surgical patients. Prog Clin Biol Res (1985) 0.78
Expression, purification, and characterization of the recombinant proform of eosinophil granule major basic protein. J Immunol (1995) 0.77
Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients. Am J Kidney Dis (2001) 0.77
Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. II. Dependence on IgE-mediated release. J Immunol (1979) 0.77
Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. I. Characteristics of enhancement. J Immunol (1979) 0.77
Treatment of azotemic, nonoliguric, anemic patients with human recombinant erythropoietin raises whole-blood viscosity proportional to hematocrit. Nephron (1991) 0.77
Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assays. J Immunol Methods (1999) 0.76
Inhibition of human polymorphonuclear leukocyte-derived histaminase activity by H-2 antagonists. Biochem Pharmacol (1978) 0.76
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma. Eur J Cancer Clin Oncol (1988) 0.76
Effect of the calcium ionophore A23187 and aspirin on histamine release in vitro from leukocytes of aspirin-intolerant donors. Int Arch Allergy Appl Immunol (1984) 0.76
Social skills training in the rehabilitation of patients with traumatic closed head injury. Arch Phys Med Rehabil (1988) 0.76
IgE-mediated sensitivity to Trichophyton rubrum in a patient with chronic dermatophytosis and Cushing's syndrome. J Allergy Clin Immunol (1988) 0.75
High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia. Br Med J (Clin Res Ed) (1988) 0.75
Staining whole mounts of an insect (Tribolium confusum) reproductive system for succinic dehydrogenase and nonspecific esterase. Stain Technol (1968) 0.75
Acute ischaemic cerebrovascular accident after autologous bone marrow transplantation. Eur J Haematol (1996) 0.75
[Current approach to the management of patients with hemato-oncologic diseases]. Ned Tijdschr Geneeskd (1987) 0.75
Metabolism of ethyl dibunate-14C: an antitussive drug. Biochem Pharmacol (1966) 0.75
The thyroid in the spontaneously hypertensive rat: a light and electron microscopic study. Am J Anat (1977) 0.75
Analysis of lognormal survival data. Math Biosci (1997) 0.75
Interrelationships of locus of control content dimensions and hopelessness. J Clin Psychol (1985) 0.75
Histochemistry of the lantern of the firefly Photinus pyralis (Coleoptera: lampyridae). Ann Entomol Soc Am (1967) 0.75
Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease. Infection (1997) 0.75
CGS 26529: the biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action. Inflamm Res (1995) 0.75
Physician house calls: a complement to hospital-based medical care. J Am Geriatr Soc (1977) 0.75
Effect of solvent on the histamine-releasing, enzyme-releasing, and mitogenic properties of the calcium ionophore A23187. Immunopharmacology (1979) 0.75
Histochemical changes in the firefly lantern during the aging process. J Gerontol (1966) 0.75
Community eye health. J Indian Med Assoc (1999) 0.75
Simplified technique for the T-globulin cancer test. J Natl Cancer Inst (1973) 0.75
Fenspiride -14 C: its distribution, excretion and metabolism in the rat. Arch Int Pharmacodyn Ther (1973) 0.75
Donor sensitivity to basophil activation by eosinophil granule major basic protein. Int Arch Allergy Appl Immunol (1985) 0.75
The immunopharmacologic and anti-inflammatory properties of RMI 9563 with special reference to its effect on the complement system. Agents Actions (1978) 0.75
Studies on the mechanism of cellular death. 3. Changes in proteins and connective tissue elements during early and late cardiac necrosis. J Gerontol (1967) 0.75
Carboxy-substituted cinnamides: a novel series of potent, orally active LTB4 receptor antagonists. J Med Chem (1999) 0.75
Systemic persistence of homologous guinea pig skin-sensitizing antibodies. Int Arch Allergy Appl Immunol (1979) 0.75
Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutropenia. Neth J Med (1992) 0.75
Chromogenic endotoxin determination in blood--clinical relevance. Klin Wochenschr (1982) 0.75
LTB4-induced transient neutropenia in the rat: a model for evaluating efficacy and bioavailability of LTB4 receptor antagonists. J Pharmacol Toxicol Methods (1993) 0.75
Bone-marrow aspiration. Br Med J (Clin Res Ed) (1981) 0.75
Chronic lymphocytic leukaemia and associated second malignancy. Neth J Med (1986) 0.75
Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor. Adv Prostaglandin Thromboxane Leukot Res (1989) 0.75
Quantitative chromogenic endotoxin determination in cerebrospinal fluid. Clin Chim Acta (1983) 0.75
Inhibition of glucose utilization for acetylcholine synthesis by cerebrospinal fluid. J Neurochem (1976) 0.75